Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Evaluation of the Pharmacokinetics and Safety of Boceprevir and Ucalm (St John&Apos;s Wort) When Co-administered to Male and Female Healthy Volunteers.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01663922
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:50.498119+00:00
Published At
2014-09-29T00:00:00+00:00
Record Updated At
2014-09-29
Results Posted At
2014-09-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hepatitis C"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-09-29"
protocolSection.identificationModule.nctId
"NCT01663922"
protocolSection.identificationModule.officialTitle
"Phase I Evaluation of the Pharmacokinetics and Safety of Boceprevir and Ucalm (St John\u0026Apos;s Wort) When Co-administered to Male and Female Healthy Volunteers."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-09-29"

Study condition terms

  • Hepatitis C (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.